Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.450
-0.070 (-4.61%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $385.91 million as of July 24, 2026. Its market cap has decreased by -45.90% in one year.
Market Cap
385.91M
Enterprise Value
525.60M
1-Year Change
-45.90%
Ranking
Category
Stock Price
$1.45
ChartMarket Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $944.40M to $385.91M, a decrease of -59.14%. That is a compound annual growth rate of -10.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 385.90M | -27.13% |
| Dec 31, 2025 | 529.60M | -15.32% |
| Dec 31, 2024 | 625.40M | -44.19% |
| Dec 29, 2023 | 1.12B | 546.94% |
| Dec 30, 2022 | 173.20M | -54.23% |
| Dec 31, 2021 | 378.40M | -19.08% |
| Dec 31, 2020 | 467.60M | -21.25% |
| Dec 31, 2019 | 593.80M | -54.96% |
| Dec 31, 2018 | 1.32B | 39.60% |
| Jun 22, 2018 | 944.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 418.95M |
| Larimar Therapeutics | 418.58M |
| Eupraxia Pharmaceuticals | 410.72M |
| Evommune | 407.73M |
| Puma Biotechnology | 407.70M |
| C4 Therapeutics | 403.57M |
| Inhibikase Therapeutics | 397.08M |
| Benitec Biopharma | 393.01M |